Andrew Fordyce - Novozymes AS Insider

Novozymes AS -- USA Stock  

USD 52.55  0.000001  0.00%

Executive VP of Food and Beverages

Mr. Andrew Fordyce was Executive Vice President, Food Beverages at Novozymes AS since February 8, 2016. Previously, he was Executive Vice President of Business Operations at the Company from April 1, 2013 until February 8, 2016. He was previously Vice President of Sales and Customer Solutions. Since joining the Company in 1993, he has held several positions in commercial operations, research and development and production in Denmark, Switzerland and the United States. He holds Doctorate of Philosophy degree in Chemical Engineering from the University of Texas at Austin.
Age: 54  EVP Since 2016  Ph.D    
45 44 46 00 00

Management Efficiency

The company has return on total asset (ROA) of 13.68 % which means that it generated profit of $13.68 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 27.12 % meaning that it generated $27.12 on every $100 dollars invested by stockholders.
The company has accumulated 375.71 M in total debt with debt to equity ratio (D/E) of 20.1 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Novozymes AS has Current Ratio of 1.31 which is within standard range for the sector.

Similar Executives

Found 1 records

EVP Since

Richard EgosiTeva Pharmaceutical Industries

Entity Summary

Novozymes AS produces and sells industrial enzymes and microorganisms worldwide. Novozymes AS was founded in 1925 and is headquartered in Bagsvaerd, Denmark. Novozymes AS is traded on OTC Market in USA.Novozymes AS (NVZMF) is traded on OTC Market in USA. It is located in Krogshoejvej 36 and employs 5,973 people.

Did you try this?

Run Price Exposure Probability Now

Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
Hide  View All  NextLaunch Price Exposure Probability
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Novozymes AS to your portfolio

Top Management

Novozymes AS Leadership Team
Thomas Videbaek, COO
Tobias Bjorklund, Executive
Benny Loft, CFO
Kasim Kutay, Director
Anders Knudsen, Director
Lena Olving, Director
Mathias Uhlen, Director
Anders Lund, President
Agnete RaaschouNielsen, Director
Thomas Nagy, EVP
Henrik Gurtler, Chairman
Per Falholt, Executive, MBA
Joergen Rasmussen, Director
Andrew Fordyce, EVP, Ph.D
Lena Halskov, Director
Kim Stratton, Director
Tina Fanoe, President
Martin Riise, Executive
Peder Nielsen, CEO
Prisca HavranekKosicek, CFO
Thomas Bomhoff, Executive
Lars Green, Director
HeinzJuergen Bertram, Director, Ph.D
Lars Koeppler, Director

Stock Performance

Novozymes AS Performance Indicators